DERMATOPHAGOIDES PTERONYSSINUS ALLERGEN EXTRACT (Acarizax®)
Clinical Indication
Immunotherapy treatment for house dust mite and allergic rhinitis in paediatrics.
Comments
Date of classification
December 2022
Orange
Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.